Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $258,969 - $289,720
3,072 New
3,072 $283,000
Q1 2024

Aug 13, 2024

SELL
$72.54 - $95.56 $11,461 - $15,098
-158 Reduced 5.14%
2,914 $278,000
Q2 2023

Aug 08, 2023

SELL
$81.41 - $94.33 $434,159 - $503,061
-5,333 Reduced 19.46%
22,070 $2.08 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $80,275 - $91,355
-1,081 Reduced 3.8%
27,403 $2.27 Million
Q4 2022

Feb 08, 2023

BUY
$68.3 - $87.44 $89,814 - $114,983
1,315 Added 4.84%
28,484 $2.13 Million
Q3 2022

Oct 27, 2022

BUY
$82.37 - $107.29 $67,790 - $88,299
823 Added 3.12%
27,169 $2.25 Million
Q2 2022

Aug 08, 2022

SELL
$86.5 - $128.27 $84,510 - $125,319
-977 Reduced 3.58%
26,346 $2.51 Million
Q1 2022

May 04, 2022

BUY
$101.96 - $128.34 $147,026 - $185,066
1,442 Added 5.57%
27,323 $3.22 Million
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $337,192 - $414,255
3,170 Added 13.96%
25,881 $3.35 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $380,972 - $454,420
3,702 Added 19.47%
22,711 $2.57 Million
Q2 2021

Aug 12, 2021

BUY
$83.84 - $104.76 $23,978 - $29,961
286 Added 1.53%
19,009 $1.97 Million
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $1.3 Million - $1.5 Million
16,504 Added 743.76%
18,723 $1.57 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $78,859 - $100,353
1,100 Added 98.3%
2,219 $202,000
Q3 2020

Nov 04, 2020

BUY
$67.19 - $87.44 $75,185 - $97,845
1,119 New
1,119 $89,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $45,701 - $70,632
-872 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $62,522 - $71,582
872 New
872 $203,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.